MedPath

Effect of Choline Fenofibrate (SLV348) on Macular Edema

Phase 2
Completed
Conditions
Diabetic Macular Edema
Interventions
Registration Number
NCT00683176
Lead Sponsor
Abbott Products
Brief Summary

The purpose of this study is to evaluate the effect of choline fenofibrate on the regression of macular edema in eyes of subjects with type 2 diabetes mellitus (T2DM) presenting with diabetic macular edema (DME)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Placebo-
1Choline Fenofibrate-
Primary Outcome Measures
NameTimeMethod
Total macular volume measurement on OCT, after central reading (assessed at baseline and after 3, 6, 9 and 12 months of treatment)12 months
Secondary Outcome Measures
NameTimeMethod
OCT variables (Retinal Thickness, Retinal thickening)12 months
ETDRS macular and hard exudate grading, E-ETDRS visual acuity, ETDRS retina grading, at least 2 step progression, Laser photocoagulation for diabetic macular edema12 months
Lipids12 months
SBP/DBP, Urinary albumin excretion rate12 months

Trial Locations

Locations (21)

Site Reference ID/Investigator# 54274

🇩🇰

Glostrup, Denmark

Site Reference ID/Investigator# 54264

🇪🇸

Santiago de Compostela, Spain

Site Reference ID/Investigator# 54270

🇨🇿

Usti nad Labem, Czech Republic

Site Reference ID/Investigator# 54271

🇬🇧

Liverpool, United Kingdom

Site Reference ID/Investigator# 54280

🇪🇸

Madrid, Spain

Site Reference ID/Investigator# 54275

🇭🇺

Zalaegerszeg - Pozva, Hungary

Site Reference ID/Investigator# 54272

🇮🇹

Udine, Italy

Site Reference ID/Investigator# 54268

🇧🇬

Sofia, Bulgaria

Site Reference ID/Investigator# 54277

🇭🇺

Gyor, Hungary

Site Reference ID/Investigator# 54269

🇭🇺

Budapest, Hungary

Site Reference ID/Investigator# 54291

🇧🇬

Sofia, Bulgaria

Site Reference ID/Investigator# 54267

🇨🇿

Brno, Czech Republic

Site Reference ID/Investigator# 54282

🇨🇿

Ostrava-Vitkovice, Czech Republic

Site Reference ID/Investigator# 54279

🇧🇬

Sofia, Bulgaria

Site Reference ID/Investigator# 54273

🇧🇬

Sofia, Bulgaria

Site Reference ID/Investigator# 54283

🇨🇿

Prague, Czech Republic

Site Reference ID/Investigator# 54265

🇵🇱

Gdansk, Poland

Site Reference ID/Investigator# 54266

🇵🇱

Katowice, Poland

Site Reference ID/Investigator# 54263

🇩🇪

Leipzig, Germany

Site Reference ID/Investigator# 54284

🇩🇪

Muenster, Germany

Site Reference ID/Investigator# 54293

🇳🇱

Amsterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath